This grant funds innovative research to improve the health and quality of life for melanoma survivors, requiring collaboration with survivors or their supporters, with up to $1.02M per award over 3 years.
Funder: Dept. of the Army -- USAMRAA
Due Dates (Anticipated): October 2026
Funding Amounts: ~$2.04M total; up to $1.02M per award (2 anticipated awards, max 3 years)
Summary: Supports innovative research to improve the health and well-being of melanoma survivors, their families, and care partners.
Key Information: Application must include a melanoma consumer collaborator; clinical trials allowed.
This opportunity supports research focused on melanoma-specific survivorship, aiming to improve the quality of life, health, and function of melanoma survivors, their families, and care partners. Projects should emphasize innovative and impactful approaches that go beyond survival alone to address broader survivorship needs. Proposals focusing solely on animal models or survival without consideration of quality of life, overall health, or function are not responsive. Clinical trials are permitted. A distinctive requirement is the inclusion of at least one melanoma consumer collaborator—either a survivor, family member, care partner, or a melanoma-community supporting organization—to provide lived experience expertise throughout the research project.